InfuSystem Holdings (INFU) Net Cash Flow (2010 - 2026)
InfuSystem Holdings (INFU) posted Net Cash Flow of -$1.1 million for Q1 2026, down 148.41% on a QoQ basis from $2.2 million in Q4 2025, and down 210.32% year-over-year from $979000.0 in Q1 2025.
InfuSystem Holdings (INFU) Net Cash Flow (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Net Cash Flow history runs 17 years deep, the most recent figure standing at -$1.1 million for Q1 2026.
- Quarterly Net Cash Flow fell 210.32% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $600000.0 (down 12.28% YoY) and the FY2025 annual result came in at $2.7 million, up 798.31% from the prior year.
- Net Cash Flow was -$1.1 million for Q1 2026 at InfuSystem Holdings, down from $2.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $2.2 million in Q4 2025 and bottomed at -$1.1 million in Q1 2026.
- A 5-year average of $112941.2 and a median of $70000.0 in 2023 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 5100.0% in 2022, while the deepest fall reached 1042.86% in 2022.
- InfuSystem Holdings' Net Cash Flow stood at -$198000.0 in 2022, then soared by 135.35% to $70000.0 in 2023, then surged by 110.0% to $147000.0 in 2024, then soared by 1417.69% to $2.2 million in 2025, then sank by 148.41% to -$1.1 million in 2026.
- Business Quant data shows INFU's Net Cash Flow at -$1.1 million in Q1 2026, $2.2 million in Q4 2025, and $235000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 Mn |
| Mar 31, 2026 | -1.08 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 235,000.00 |
| Sep 30, 2025 | 235,000.00 |
| Jun 30, 2025 | -786,000.00 |
| Jun 30, 2025 | -786,000.00 |
| Mar 31, 2025 | 979,000.00 |
| Mar 31, 2025 | 979,000.00 |
| Dec 31, 2024 | 147,000.00 |
| Dec 31, 2024 | 147,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | -676,000.00 |
| Jun 30, 2024 | -676,000.00 |
| Mar 31, 2024 | 591,000.00 |
| Mar 31, 2024 | 591,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |